References
Geddes J, Freemantle N, Harrison P, Bebbington P (2000) Atypical antipsychotics in the treatment of schizophrenia : systematic overview and meta-regression analysis. BMJ 321:1371–1376
Haas SJ, Hill R, Krum H, Liew D et al (2007) Clozapine-associated myocarditis: a review of 116 cases of suspected myocarditis associated with the use of clozapine in Australia during 1993–2003. Drug Saf 30:47–57
Leo RJ, Kreger JL, Kim KY (1996) Cardiomyopathy associated with clozapine. Ann Pharmacother 30:603–605
La Grenade L, Graham D, Trontell A (2001) Myocarditis and cardiomyopathy associated with clozapine in the United States. N Engl J Med 345:224–225
Rostagno C, Di Norscia G, Placidi GF, Gensini GF (2008) Beta-blocker and angiotensin-converting enzyme inhibitor may limit certain cardiac adverse effects of clozapine. Gen Hosp Psychiatry 30:280–283
Acknowledgments
The authors have no financial involvement connected to the work.
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Rostagno, C., Domenichetti, S., Pastorelli, F. et al. Clozapine associated cardiomyopathy: a cluster of 3 cases. Intern Emerg Med 6, 281–283 (2011). https://doi.org/10.1007/s11739-010-0468-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11739-010-0468-4